GeNeuro SA (GNRO.PA)

EUR 0.08

(6.38%)

Annual Income Statements

(In EUR)
Breakdown 2023 2022 2021 2020 2019 2018
Revenue - - - - - 7463.10
Cost of Revenue 293.8 Thousand 288.5 Thousand 300.2 Thousand 334.6 Thousand 354.8 Thousand 70.9 Thousand
Gross Profit -293.8 Thousand -288.5 Thousand -300.2 Thousand -334.6 Thousand -354.8 Thousand -63.43 Thousand
Operating Expenses 14.35 Million 12.76 Million 7.23 Million 7.7 Million 9.56 Million 15.81 Thousand
Selling, General and Administrative Expenses 3.05 Million 3.07 Million 2.49 Million 3.13 Million 3.56 Million 4915.90
Research and Development Expenses 12.3 Million 9.67 Million 4.72 Million 4.53 Million 5.97 Million 12.84 Thousand
Other Expenses -1.18 Million -12.69 Thousand -23.8 Thousand -38.2 Thousand -26.5 Thousand -34.39 Thousand
Cost and Expenses 14.35 Million 13.05 Million 7.53 Million 8.04 Million 9.91 Million 15.81 Thousand
Operating Income -14.35 Million -13.05 Million -7.53 Million -8.04 Million -9.91 Million -8088.60
Interest Expense 952.6 Thousand 269.3 Thousand 40.6 Thousand 80.2 Thousand 448.5 Thousand 31 Thousand
Income Tax Expense -551.7 Thousand -1.31 Million -1 Million -553.9 Thousand -912.4 Thousand -1.91 Million
Earnings before Tax -15.3 Million -13.51 Million -7.82 Million -9.51 Million -10.37 Million -8327.80
Net Income -14.75 Million -12.19 Million -6.81 Million -8.96 Million -9.46 Million -8327.80
Earnings Per Share Basic -0.59 -0.51 -0.32 -0.45 -0.65 -0.57
Earnings Per Share Diluted -0.59 -0.51 -0.32 -0.45 -0.65 -0.57
Weighted Average Shares Outstanding 24.84 Million 23.89 Million 21.28 Million 19.96 Million 14.56 Million 14.57 Thousand
Weighted Average Shares Outstanding (Diluted) 24.84 Million 23.89 Million 21.28 Million 19.96 Million 14.56 Million 14.57 Thousand
Gross Margin - - - - - -8.50
EBIT Margin - - - - - -1.08
Profit Margin - - - - - -1.12
EBITDA -14.31 Million -11.77 Million -6.78 Million -9.1 Million -9.56 Million -8.03 Million
Earnings Before Tax Margin - - - - - -1.08

Income Statement Charts